Form D · Biotechnology

XYLOS Corp

Langhorne, PA · CIK 0001232545

Offering snapshot reported Aug 5, 2011 · SEC filing

Reported sold
$400K
Offering amount: $1.98M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 25, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 5, 2011Initial$400,000No comparison13SEC filing
Mar 16, 2011Initial$750,000No comparison16SEC filing
May 19, 2010Initial$1,500,000No comparison30SEC filing
Feb 14, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Dec 6, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-164009

Source: Form D, filed Aug 5, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Constance L. Ace Executive
Eric T. Converse Director
Paul J. Gordon Director
Mark S. Mc Nulty Director, Executive
Richard S. Mink Executive
Seth Pierrepont Director
John M. Pietruski Director
David Rovee Director
Gonzalo C. Serafica Executive
Frits Vromen Director
Gregory Zaic Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
838 Town Center Drive
Langhorne, PA, 19047